您的位置: 首页 > 农业专利 > 详情页

Substituted nicotinimide inhibitors of BTK and their preparation and use in the treatment of cancer, inflammation and autoimmune disease
专利权人:
Beijing Innocare Pharma Tech Co.; Ltd
发明人:
Chen, Xiangyang,Gao, Yingxiang,Liu, Chong,Ni, Haihong,Mulvihill, Mark
申请号:
AU2014324595
公开号:
AU2014324595B2
申请日:
2014.09.29
申请国别(地区):
AU
年份:
2018
代理人:
摘要:
Compounds of Formula I, as shown below and defined herein: and pharmaceutically acceptable salts, syntheses, intermediates, formulations, and methods of treating diseases including cancer, inflammation, and autoimmune disease mediated at least in part by Bruton's Tyrosine Kinase (BTK).
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充